Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$29.76 - $46.14 $70,174 - $108,798
2,358 Added 17.83%
15,586 $506,000
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $503,854 - $764,446
13,228 New
13,228 $517,000
Q2 2022

Aug 15, 2022

SELL
$28.03 - $45.8 $373,387 - $610,101
-13,321 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$29.24 - $44.06 $389,506 - $586,923
13,321 New
13,321 $550,000
Q2 2021

Aug 16, 2021

SELL
$44.66 - $63.06 $3.1 Million - $4.37 Million
-69,310 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$46.31 - $62.7 $1.19 Million - $1.61 Million
25,694 Added 58.91%
69,310 $3.51 Million
Q4 2020

Feb 16, 2021

BUY
$55.51 - $69.94 $1.98 Million - $2.49 Million
35,604 Added 444.38%
43,616 $2.75 Million
Q3 2020

Nov 16, 2020

SELL
$42.19 - $69.61 $93,155 - $153,698
-2,208 Reduced 21.6%
8,012 $538,000
Q2 2020

Aug 14, 2020

BUY
$27.55 - $43.28 $281,561 - $442,321
10,220 New
10,220 $428,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.